venBio Global Strategic Fund II L.P., 10% Owner at IMPEL NEUROPHARMA INC (IMPL), bought 2,759,791 shares at $15.00 ($6.8M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,309,791 | $0 | 0.0% |
| 2 | $15.00 | 450,000 | $6.8M | 100.0% |
| Total | $2.45 avg | 2,759,791 | $6.8M | 100% |
| Filing → |
| CMPI | SELL | 2022-04-29 | $3.2M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |
| AKRO | SELL | 2020-02-10 | $330K | — | Filing → |